Journal of the American College of Cardiology
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarctionResults of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial
Kenneth W Mahaffey, Joseph A Puma, N.Alejandro Barbagelata, Marcelo F DiCarli, Massoud A Leesar, Kevin F Browne, Paul R Eisenberg, Roberto Bolli, A.Cecilia Casas, Victor Molina-Viamonte, Cesare Orlandi, Roger Blevins, Raymond J Gibbons, Robert M Califf, Christopher B Granger and for the AMISTAD Investigators
Table 3
Table 3
Number and Percent of Patients With Assessment of Myocardium at Risk and Final Infarct Sizelegend
| Anterior | Nonanterior | Total | ||||
|---|---|---|---|---|---|---|
| Adenosine (n = 47) | Placebo (n = 45) | Adenosine (n = 72) | Placebo (n = 72) | Adenosine (n = 119) | Placebo (n = 117) | |
| Acute image | 12 (25%) | 9 (20%) | 28 (39%) | 19 (26%) | 40 (34%) | 28 (24%) |
| Final image | 39 (83%) | 38 (84%) | 62 (86%) | 58 (81%) | 101 (85%) | 96 (82%) |
| Acute and final image | 12 (25%) | 8 (18%) | 25 (35%) | 17 (24%) | 37 (31%) | 25 (21%) |
↵legend Data presented are number (%) of patients.
Advertisement